Search Browse Earnings

Eledon Pharmaceuticals, Inc.

Nasdaq:ELDN

Pharmaceutical Preparations·IRVINE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2016

Adj. EBITDA

-$88.4M

FY 2023

Net Income

-$116.5M

FY 2024

EPS (Diluted)

-$4.73

FY 2024

Stock Price

$2.79

+6.5%

2026-03-06

52W Range

$1.35 – $4.60

P/E Ratio

-0.6x

Market Cap

$167.2M

Cash

$4.6M

FY 2024

Total Debt

—

Net Cash

$4.6M

FY 2016

Enterprise Value

$162.6M

Debt / EBITDA

0.1x

FY 2016

EV / EBITDA

-1.8x

Employees

—